Annual conference showcases medicinal chemistry advancements, fostering collaboration among early-career researchers and experts.
The 33rd Annual Conference of the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), held in Nantes from 11 to 13 June 2025, marked a significant expansion of the organization’s scope and collaborative efforts. Building on the success of the previous meeting in Coimbra, the 2025 edition brought together 168 participants and featured a comprehensive scientific programme comprising 102 abstracts. A key highlight of this year’s conference was the collaboration with COST Action OneHealthdrugs and the Paul Ehrlich (PE) Euro-PhD Network, fostering interdisciplinary exchange and identifying future research synergies. The event included 1 computational workshop and 8 keynote lectures by international experts, alongside a strong emphasis on early-career researchers, with 25 oral presentations and 25 flash poster communications. In addition, 77 posters were presented across three dedicated sessions. All the presentations were eligible for 18 conference awards. Staying true to the GP2A and PE mission, the conference provided a dynamic platform for young scientists to engage with established researchers.
No takes yet. Share an insight, caveat, or question.
McCarthy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: